Education
About Us
Working with TipRanks
Follow Us
Aditxt, Inc. (ADTX)
NASDAQ:ADTX
ADTX Stock Chart & Stats
$1.12
-$0.03(-13.16%)
At close: 4:00 PM EST
$1.12
-$0.03(-13.16%)
Day’s Range― - ―
52-Week Range$2.20 - $10,140.11
Previous Close$0.18
Volume28.68M
Average Volume (3M)223.92K
Market Cap
$626.58K
Enterprise Value$9.09M
Total Cash (Recent Filing)$163.04K
Total Debt (Recent Filing)$5.53M
Price to Earnings (P/E)―
Beta1.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-161133.90
Shares Outstanding559,444
10 Day Avg. Volume193,922
30 Day Avg. Volume223,916
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.07
Price to Sales (P/S)4.67
P/FCF Ratio-0.04
Enterprise Value/Market Cap14.50
Enterprise Value/Revenue1.53K
Enterprise Value/Gross Profit-44.78
Enterprise Value/Ebitda-0.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-103,926,100
Revenue Forecast (FY)$1.20M
Aditxt News
ADTX FAQ
What was Aditxt, Inc.’s price range in the past 12 months?
Aditxt, Inc. lowest stock price was $2.20 and its highest was $10140.11 in the past 12 months.
What is Aditxt, Inc.’s market cap?
Aditxt, Inc.’s market cap is $626.58K.
When is Aditxt, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aditxt, Inc.’s earnings last quarter?
Currently, no data Available
Is Aditxt, Inc. overvalued?
According to Wall Street analysts Aditxt, Inc.’s price is currently Overvalued.
Does Aditxt, Inc. pay dividends?
Aditxt, Inc. does not currently pay dividends.
What is Aditxt, Inc.’s EPS estimate?
Aditxt, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aditxt, Inc. have?
Aditxt, Inc. has 559,444 shares outstanding.
What happened to Aditxt, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aditxt, Inc.?
Currently, no hedge funds are holding shares in ADTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aditxt, Inc.
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Technical Analysis
Scinai Immunotherapeutics
―
GRI Bio
―
Dermata Therapeutics
―
CERo Therapeutics Holdings
―
Conduit Pharmaceuticals
―
Ownership Overview
<0.01% Insiders
1.93% Mutual Funds
― Other Institutional Investors
98.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---